Assistant Professor, Medicine, UCLA School of Medicine
Rheumatology
Dr. Veena K. Ranganath, MD
|
|
Give Review
Doctor Veena K. Ranganath, MD is an expert in the field of Rheumatology. She researched medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. She received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACR)" and "Fellow". Dr. Veena K. Ranganath is a published doctor and has 26 publications published. The lastest was: 'Comprehensive appraisal of MRI findings in sustained RA remission: Sub-study of the TEAR trial.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Comprehensive appraisal of MRI findings in sustained RA remission: Sub-study of the TEAR trial.
- Older Age at Rheumatoid Arthritis Onset and Comorbidities Correlate With Less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index Resp...
- Association of Paraoxonase 1 gene polymorphisms and enzyme activity with carotid plaque in rheumatoid Arthritis.
- The utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid Arthritis: Report from the imaging group of the...
- Comorbidities are associated with poorer outcomes in community patients with rheumatoid Arthritis.
- Validation of methotrexate-first strategy in early poor prognosis rheumatoid Arthritis: Results from a randomized, double-blind, 2-year trial.
- Clinical Response Within 12 Weeks as a Predictor of Future Low Disease Activity in Patients with Early RA: Results from the TEAR Trial.
- Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid Arthritis: results of a phase 1, randomized, open-label trial.
- Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of north america cohort of rheumatoid Arthritis patients.
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced Osteoporosis.
- Remission in rheumatoid Arthritis.
- Disease-modifying antirheumatic drug use in the elderly rheumatoid Arthritis patient.
- Comparison of composite measures of disease activity in an early seropositive rheumatoid Arthritis cohort.
- Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid Arthritis cohort.
- Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid Arthritis in y...
- Increased radiographic damage scores at the onset of seropositive rheumatoid Arthritis in older patients are associated with osteoArthritis of the hands, but not with ...
- Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or Osteoporosis.
- Functional improvement after patients with rheumatoid Arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the...
- Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive Rheumatoid art...
- Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited Systemic sclerosis.
- Equivalent responses to Disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheuma...
- Through the looking glass: "remission" in rheumatoid Arthritis.
- Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid Arthritis patients: evidence from the CORRONA registry.
- ACR remission criteria and response criteria.
- Differences in presentation of younger and older Systemic sclerosis patients in clinical trials.
Schools
University of California At Los Angeles
Va Greater La Hlthcare Sys
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
- View All
Conditions Treated
- Adhesive Capsulitis
- Arthritis
- Behçet's Disease
- Bursitis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACR)
- Fellow
Education
-
UCLA Medical Center -
VA Greater Los Angeles Healthcare System -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1730109323 | |
| NPPES Provider LastName | RANGANATH | |
| NPPES Provider FirstName | VEENA | |
| NPPES Provider ZIPCode | 90095 | |
| NPPES Provider State | CA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 247.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730109323 |
| Last Name Of The Provider | RANGANATH |
| First Name Of The Provider | VEENA |
| View All |
Similar Doctors
|
|
Dr. Harold E. Paulus, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn Ehresmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David T. Yu, MD |
|
|
Dr. Alan Weinberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernest Brahn, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Peter J. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veena A. Rao, MD |
|
|
Dr. Christina M. Charles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen M. Au, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodanthi C. Kitridou, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Puja P. Khanna, MD |
|
|
Dr. Matthew L. Sofer, MD |
|
|
Dr. Haoling Weng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dinesh M. Shah, MD |
|
|
Dr. Phot Luisiri, MD
This Doctor is OpenDoctor Recommended.
|